Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gründer

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Der Nervenarzt|June 11, 2013
[Can long-term treatment with antipsychotic drugs lead to structural brain damage? Against]G Gründer
Der Nervenarzt|March 18, 2016
[Significance of the German Act on the Reform of the Market for Medicinal Products for psychopharmacotherapy]G Gründer
Der Nervenarzt|November 18, 2015
[Not Available]G Gründer
Der Nervenarzt|November 19, 2014
[Neuroenhancement]G Gründer, T Bartsch
Fortschritte Der Neurologie-Psychiatrie|August 12, 2003
[The next generation of "atypical" antipsychotics: the role of positron emission tomography]G Gründer, D F Wong
Pharmacopsychiatry|July 25, 2008
Aripiprazole reduces serum prolactin in a woman with prolactinoma and acute psychosisA J Sheldrick, G Gründer
Der Nervenarzt|January 27, 2006
[Monoaminergic function in major depression. A possibly helpful tool for choosing treatment strategy]O Moeller, C Norra, G Gründer
Der Nervenarzt|January 5, 2002
[Which properties make a neuroleptic "atypical"?]G Gründer, I Vernaleken, O Benkert
Pharmacopsychiatry|October 23, 2008
Imaging studies - differential action of typical and atypical antipsychotics in a network perspectiveI Vernaleken, P Cumming, G Gründer
Der Nervenarzt|September 8, 2012
[Basic principles of therapy with neuropsychotropic drugs]G Gründer, T Veselinović, M Paulzen
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Der Nervenarzt|June 11, 2013
[Can long-term treatment with antipsychotic drugs lead to structural brain damage? Against]G Gründer
Der Nervenarzt|March 18, 2016
[Significance of the German Act on the Reform of the Market for Medicinal Products for psychopharmacotherapy]G Gründer
Der Nervenarzt|November 18, 2015
[Not Available]G Gründer
Der Nervenarzt|November 19, 2014
[Neuroenhancement]G Gründer, T Bartsch
Fortschritte Der Neurologie-Psychiatrie|August 12, 2003
[The next generation of "atypical" antipsychotics: the role of positron emission tomography]G Gründer, D F Wong
Pharmacopsychiatry|July 25, 2008
Aripiprazole reduces serum prolactin in a woman with prolactinoma and acute psychosisA J Sheldrick, G Gründer
Der Nervenarzt|January 27, 2006
[Monoaminergic function in major depression. A possibly helpful tool for choosing treatment strategy]O Moeller, C Norra, G Gründer
Der Nervenarzt|January 5, 2002
[Which properties make a neuroleptic "atypical"?]G Gründer, I Vernaleken, O Benkert
Pharmacopsychiatry|October 23, 2008
Imaging studies - differential action of typical and atypical antipsychotics in a network perspectiveI Vernaleken, P Cumming, G Gründer
Der Nervenarzt|September 8, 2012
[Basic principles of therapy with neuropsychotropic drugs]G Gründer, T Veselinović, M Paulzen
Pageof 6